V600E mutation in determining the invasiveness of papillary carcinoma of thyroid (PTC) and its related influencing factors.
Methods:
A total of 174 PTC patients who underwent ultrasound guided fine- needle aspiration cytology (FNAC) and
BRAF
V600E mu
tation detection before surgery were selected. All PTC patients were divided into mutation group 151 cases and no mutation group of 23 cases. The clinical pathological features and the ultrasonic characteristics between the two groups were compared
and single factor analyzed the correlation between observational indexes and
BRAF
V600E mutation
binary logistic regression analysis screened out risk factors closely related to
BRAF
V600E mutation.
Results:
There was no statistical difference in
BRAF
V600E mutation and clinicopathological features between the two groups (
P
>0.05)
and there was a statistical difference in some ultrasonic features (nodule position
maximum diameter
calcification
and posterior attenuation) between them (
P
<0.05). Only the calcification and location of cancer nodules were closely related to
BRAF
V600E (
P
<0.05).
BRAF
V600E mutations were more likely to occur in the PTC nodules which were close to the anterior capsule and without calcification.
Conclusion:
BRAF
V600E mutation has no obvious correlation with PTC invasive characteristics
and it is closely related to calcification and location in ultrasonic features. When the suspected PTC nodule has no calcification or is close to the anterior capsule